630-580-1088 sales@ambeed.com
Structure Search

List Search MOL Search Structure Search

0
Chemistry
Asymmetric Synthesis >>Chiral Building BlocksChiral Catalysts, Chiral Ligands and Chiral ReagentsChiral Resolution ReagentsCatalysis Chemistry >>Achiral Crown LigandsC-H ActivationCarbon-Donor LigandsChiral Crown LigandsCross-CouplingCross-Coupling Using Transition Metal CatalystsDACH or Trost LigandsDiketone LigandsHydrogenationChemical Biology >>Conjugation ChemistryGlycoscienceLinkers and CrosslinkersNucleic Acid ChemistryPEGylation
Peptide ChemistryPhotolabile Protecting GroupHeterocyclic Building Blocks >>Acridinium SeriesAliphatic HeterocyclesAromatic HeterocyclesAzetidinesBenzimidazolesBenzisoxazolesBenzodioxansBenzofuransBenzothiazolesInorganic reagents >>Inorganic reagentOrganic Building Blocks >>Acyl ChloridesAlcoholsAldehydesAliphatic Chain HydrocarbonsAliphatic Cyclic Hydrocarbons
AlkenylsAlkylsAlkynylsAmidesOrganometallic Reagents >>Grignard ReagentsOrganoarsenicOrganobismuthOrganoboronOrganogermaniumOrganolithiumOrganomercuryOrganosiliconOrganotinSpecialty Synthesis >>Enzyme-Mediated SynthesisFluorous SynthesisIonic LiquidsSolid Supported SynthesisStains and Dyes >>
Acid DyesAzoic DyesBasic DyesDirect DyesDisperse DyesDye IntermediatesMordant DyesOil DyesOther Stains and DyesSynthetic Reagents >>Acids and BasesC-C Bond FormationC-X Bond Formation (Halogen)C-X Bond Formation (Non-Halogen)Chelation and Complexation CompoundsCondensation AgentsCouplingDehydrating ReagentsFluorination Reagents
Pharmaceutical Intermediates
Analgesics >>BenzhydrocodoneBicifadineCapsaicinCelecoxibDebio-0827DexamethasoneElagolix SodiumEsketamine HydrochlorideIbuprofen sodiumAnesthetics >>CiprofolEsketamine HydrochlorideFospropofol Fospropofol DisodiumLevobupivacaine RemimazolamRemimazolam BesilateRemimazolam besylateRopivacaineAnti-Addiction Agents >>Kakonein
Lofexidine HydrochlorideVarenicline Anti-inflammatory Agents >>ApremilastAsunaprevirATB-346 RelatedBalsalazide BaricitinibBencycloquidium BromideBudesonideCefiderocol Sulfate TosylateCeftaroline Fosamil AcetateAntibacterials >>AFN-1252 RelatedAlatrofloxacin Bedaquiline FumarateBesifloxacin BrilacidinCaspofungin AcetateCefiderocol Sulfate TosylateCefilavancinCeftaroline Fosamil
Anticonvulsants >>BrivaracetamCannabidiolEscitalopram OxalateEslicarbazepine Acetate RelatedFosphenytoinGabapentin EnacarbilJNJ-10234094LacosamideLevetiracetam RelatedAntidementia Agents >>Azeliragon RelatedDavunetideDonepezil HydrochlorideDonepezil RelatedEnsaculinFlorbetaben Flortaucipir F 18Flutemetamol IdalopirdineAntidepressants >>4-Chlorokynurenine
AgomelatineAgomelatine RelatedAllopregnanolone RelatedAmibegronAmitifadineAripiprazole RelatedBasimglurantBefloxatoneAntiemetics >>AprepitantAprepitant RelatedDolasetron RelatedDolasetron Mesylate HydrateFosaprepitant DimeglumineFosaprepitant RelatedOlanzapinePalonosetron RelatedPalonosetron HydrochlorideAntifungals >>Anidulafungin RelatedCabotegravirMore >>
Inhibitors/Agonists
ADC >>ADC LinkerADC Linker with PayloadADC ToxinAnti-infection >>3CLproAntibacterialAntifungalAntiparasiticAntiprotozoalAntiviralBVDVCMVDengue VirusApoptosis >>Apoptosis InducerBcl-2c-Mycc-RETC/EBPCARDCaspase
DAPKIAPAutophagy >>AutophagyLC3LRRK2LysosomemitoNEETPPTSPHKTFEBULKBiochemical Reagent >>Cationic & Neutral LipidsDendrimersDye ReagentCell Cycle >>APCAurora KinaseBUBCasein KinaseCdc25
CDKChkCRM1DHFRCytoskeleton >>ActinArp2/3 ComplexCytoplasmic dyneinDynaminFAKFilamin-AGap JunctionIntegrinMicrotubule/TubulinDNA Damage >>AP endonucleaseATAD5ATM/ATRBRCADNA Alkylator/CrosslinkerDNA-PKMore >>
Material Science
Aggregation-Induced Emission >>Other AIE BlocksTetraphenylethylene SeriesElectronic Materials >>Battery MaterialsDye-Sensitized Solar Cell (DSSC) MaterialsElectronic MaterialLiquid Crystal (LC) MaterialsMolecular ConductorsOrganic Light-Emitting Diode (OLED) MaterialsOrganic Solar Cell (OPV) MaterialsOrganic Transistor (OFET) MaterialsPerovskite Solar Cell (PSC) MaterialsMagnetic Materials >>Magnetic Ionic LiquidsMagnetic MaterialMagnetic Metal Complexes Organic Radicals Material Building Blocks >>Ligands for Functional Metal ComplexesLiquid Crystal (LC) Building BlocksPhthalocyanine Building BlocksPolymer and Macromolecule Semiconductor Building BlocksSmall Molecule Semiconductor Building BlocksSolubility Enhancing Reagents
Supramolecular Host Materials Nanomaterials >>Carbon NanomaterialsCeramic MembranesDendrimersGold NanoparticlesIron Oxide NanoparticlesMaterials by ApplicationMesoporous MaterialsMetals and Metal AlloysNano Minerals: NanoclaysOptical Materials >>Coumarin DyesCyanine and Squarylium DyesDCM DyesDipyrromethene DyesFluorescence MaterialsFluorescent ProbesHeat and Pressure Sensitive DyesNear-Infrared (NIR) DyesOrganic Non-Linear Optical (NLO) MaterialsOrganic ligands for MOF materials >>Carboxylic MOF ligandsHalogen seriesMOF ligands of nitrogenous carboxylic acids
Nitrogen containing MOF ligandsOrganic frame monomer blockOther MOF ligandsPorphyrin seriesTwo dimensional MOF ligandsOrganic monomer of COF >>Aldehyde based COF monomerAlkynyl COF monomerAmino COF monomerBoric acid COF monomerCyano COF monomerMultifunctional COF monomerOther COF monomerTriphene seriesOrganic Pigments >>Organic PigmentOther Materials >>Mateial OtherPolymer Science >>MonomersPolymer AdditivesPolymerization ReagentsPolymersResins
Life Science
ADC-linkers >>ADC-linkerAmino Acids >>Amino AcidAmino Acid DerivativesAnalytical Science >>Stable IsotopesAPIs >>API
DNA/RNA >>Nucleosides and NucleotidesEnzymes >>EnzymeOther Life Science >>CRISPR/Cas9eIFIRE1Neuronal Signaling
Sigma ReceptorPeptides >>PeptideStandard Substrates >>Standard SubstrateSteroids >>Other Steroids
Contact Us
Home Cart 0 Sign in  
X
Chemistry
Heterocyclic Building Blocks
Piperidines
tert-Butyl 4-amino-3-methoxypiperidine-1-carboxylate
Chemistry
Heterocyclic Building Blocks
Organic Building Blocks
Piperidines
Amines Amides Ethers Aliphatic Heterocycles

[ CAS No. 1260639-98-2 ]

{[proInfo.proName]} ,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 1260639-98-2
Chemical Structure| 1260639-98-2
Chemical Structure| 1260639-98-2
Structure of 1260639-98-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Bulk Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

For Research Only 88K+ Compounds Competitive Price 1-2 Day Shipping

Quality Control of [ 1260639-98-2 ]

COA NMR CNMR HPLC LC-MS

Related Doc. of [ 1260639-98-2 ]

SDS
Alternatived Products of [ 1260639-98-2 ]

Product Details of [ 1260639-98-2 ]

CAS No. :1260639-98-2 MDL No. :MFCD15474948
Formula : C11H22N2O3 Boiling Point : -
Linear Structure Formula :- InChI Key :N/A
M.W :230.30 g/mol Pubchem ID :-
Synonyms :

Calculated chemistry of of [ 1260639-98-2 ]

Physicochemical Properties

Num. heavy atoms : 16
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.91
Num. rotatable bonds : 4
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 65.19
TPSA : 64.79 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.5 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.54
Log Po/w (XLOGP3) : 0.29
Log Po/w (WLOGP) : 0.59
Log Po/w (MLOGP) : 0.32
Log Po/w (SILICOS-IT) : -0.03
Consensus Log Po/w : 0.74

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.19
Solubility : 15.0 mg/ml ; 0.0651 mol/l
Class : Very soluble
Log S (Ali) : -1.21
Solubility : 14.1 mg/ml ; 0.0613 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -0.82
Solubility : 34.9 mg/ml ; 0.151 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.29

Safety of [ 1260639-98-2 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501 UN#:
Hazard Statements:H302-H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 1260639-98-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1260639-98-2 ]

[ 1260639-98-2 ] Synthesis Path-Downstream   1~12

  • 1
  • [ 1260639-98-2 ]
  • [ 98-88-4 ]
  • 1,1-dimethylethyl 3-(methyloxy)-4-[(phenylcarbonyl)amino]-1-piperidinecarboxylate [ No CAS ]
YieldReaction ConditionsOperation in experiment
With triethylamine In dichloromethane at 20℃; for 4h; 20 To a solution of l,l-dimethylethyl 4-amino-3-(methyloxy)-l-piperidinecarboxylate D19 (2.85g) in DCM ( 100ml) was added triethylamine ( 5.2ml, 37.2mmol), and benzoyl chloride ( 2.2ml, 18.6mmol) at room temperature. The reaction mixture was stirred at room temperature for 4 hours. The resulting mixture was poured into water and extracted with DCM. The organic layer was dried over anhydrous MgS04, concentrated in vacuo to get the desired product D20 as an oil in 4.0g. LCMS [MH+] 335 (at) 1.56 and 1.61 min (isomers seen) ( 5 min run)
Reference： [1]Current Patent Assignee: GALAPAGOS - WO2012/80735, 2012, A1 Location in patent: Page/Page column 33; 34
  • 2
  • [ 79099-07-3 ]
  • [ 1260639-98-2 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 4 steps 1.1: potassium hydroxide; iodine / 2.5 h / 0 - 20 °C 2.1: potassium <i>tert</i>-butylate / tetrahydrofuran / 0.33 h / 0 °C 2.2: 0 - 20 °C 3.1: hydrogenchloride / 1,4-dioxane / 50 °C 3.2: pH 10 3.3: 4 h 4.1: sodium cyanoborohydride; ammonium acetate / methanol / 4 h / 20 °C 4.2: pH 10
Reference： [1]Current Patent Assignee: GALAPAGOS - WO2012/80735, 2012, A1
  • 3
  • [ 841286-80-4 ]
  • [ 1260639-98-2 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 3 steps 1.1: potassium <i>tert</i>-butylate / tetrahydrofuran / 0.33 h / 0 °C 1.2: 0 - 20 °C 2.1: hydrogenchloride / 1,4-dioxane / 50 °C 2.2: pH 10 2.3: 4 h 3.1: sodium cyanoborohydride; ammonium acetate / methanol / 4 h / 20 °C 3.2: pH 10
Reference： [1]Current Patent Assignee: GALAPAGOS - WO2012/80735, 2012, A1
  • 4
  • [ 942945-28-0 ]
  • [ 1260639-98-2 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1.1: hydrogenchloride / 1,4-dioxane / 50 °C 1.2: pH 10 1.3: 4 h 2.1: sodium cyanoborohydride; ammonium acetate / methanol / 4 h / 20 °C 2.2: pH 10
Reference： [1]Current Patent Assignee: GALAPAGOS - WO2012/80735, 2012, A1
  • 5
  • [ 1260639-98-2 ]
  • N-[3-(methyloxy)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4-piperidinyl]benzamide [ No CAS ]
  • N-[3-(methyloxy)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4-piperidinyl]benzamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 3 steps 1.1: triethylamine / dichloromethane / 4 h / 20 °C 2.1: hydrogenchloride / 1,4-dioxane / 20 °C 2.2: pH 10 3.1: caesium carbonate / ethanol / 2 h / 130 °C / microwave irradiation
Reference： [1]Current Patent Assignee: GALAPAGOS - WO2012/80735, 2012, A1
  • 6
  • [ 1260639-98-2 ]
  • N-[3-(methyloxy)-4-piperidinyl]benzamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1.1: triethylamine / dichloromethane / 4 h / 20 °C 2.1: hydrogenchloride / 1,4-dioxane / 20 °C 2.2: pH 10
Reference： [1]Current Patent Assignee: GALAPAGOS - WO2012/80735, 2012, A1
  • 7
  • [ 1188265-31-7 ]
  • [ 1260639-98-2 ]
YieldReaction ConditionsOperation in experiment
Stage #1: 3-methoxy-4-oxopiperidine-1-carboxylic acid t-butyl ester With ammonium acetate; sodium cyanoborohydride In methanol at 20℃; for 4h; Stage #2: With water; sodium hydroxide 7.iv; 19 To a solution of 1,1-dimethylethyl 3-(methyloxy)-4-oxo-l-piperidinecarboxylate D18 ( 2.9g) in MeOH ( 100ml), was added sodium cyanoborohydride ( 7.9g, 126mmol) and ammonium acetate ( 9.7g, 126mmol) at .T.. The reaction mixture was stirred for 4 hours. The resulting mixture was concentrated in vacuo, dissolved in water, basified with sodium hydroxide to pHIO and extracted with DCM. The organic layer was dried over anhydrous MgS04, concentrated in vacuo to get the desired product D19 in 2.85g. LCMS [MH+] 231(at) 0.83 min ( 5 min run)
Reference： [1]Current Patent Assignee: GALAPAGOS - WO2012/80735, 2012, A1 Location in patent: Page/Page column 9; 33
  • 8
  • [ 1260639-98-2 ]
  • [ 299918-69-7 ]
  • tert-butyl 4-(6-(1H-tetrazol-1-yl)nicotinamido)-3-methoxypiperidine-1-carboxylate [ No CAS ]
YieldReaction ConditionsOperation in experiment
With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; triethylamine In N,N-dimethyl-formamide at 20℃; A Step A: tert-butyl 4-(6-(1H-tetrazol-1-yl)nicotinamido)-3-methoxypiperidine-1-carboxylate To a solution of cz5-4-amino-l-Boc-3-methoxy-piperidine (120 mg, 0.52 mmol), 6-(lH-tetrazol- l-yl)nicotinic acid (100 mg, 0.52 mmol), and TBTU (200 mg, 0.63 mmol) in DMF (2.6 mL) was added triethylamine (180 μ, 1.3 mmol) at RT. The reaction mixture was stirred at RT overnight. The crude was partitioned between EtOAc and saturated aq NaHC03. The aqueous layer was extracted with EtOAc (twice). The combined organic phase was washed with brine, dried over anhydrous MgS04, filtered and concentrated in vacuo. The resulting residue was purified by prep TLC (silica gel; 10% MeOH/DCM) to provide feri-butyl 4-(6-(lH-tetrazol-l-yl)nicotinamido)-3- methoxypiperidine-l-carboxylate. -NMR (CDC13, 500 MHz), δ 9.62 (s, 1H), 8.96 (s, 1H), 8.42 (m, 1H), 8.21 (m, 1H), 6.70 (br s, 1H), 4.52 (m, 1H), 4.31 (m, 2H), 4.1 1 (m, 1H), 3.48 (s, 3Η), 2.84 (m, 2Η), 1.83 (m, 2Η), 1.51 (s, 9H); LC-MS (IE, m/z): 404 [M + If.
Reference： [1]Current Patent Assignee: MERCK & CO INC - WO2014/85210, 2014, A1 Location in patent: Page/Page column 36
  • 9
  • [ 1260639-98-2 ]
  • 3-methoxypiperidin-4-amine dihydrochloride [ No CAS ]
YieldReaction ConditionsOperation in experiment
With hydrogenchloride In 1,4-dioxane at 0 - 20℃; for 2h; 1 Step 1 - Synthesis of 3-methoxypiperidin-4-amine dih drochloride: A solution of ferf-butyl 4-amino-3-methoxypiperidine-1 -carboxylate (900 mg, 3.9 mmol) in 1 ,4-dioxane (10 mL) was cooled to 0-5 °C. 4M HCI in dioxane (9 mL) was added. After stirring 2 h at room temperature the reaction mixture was concentrated under reduced pressure. The resulting crude was triturated with petroleum ether (3 x 25 mL), filtered and dried under reduced pressure to afford 3-methoxypiperidin-4-amine dihydrochloride (700 mg, crude) as an off-white solid. LS-MS (ELSD) m/z: 131 .2 (M+H).
Reference： [1]Current Patent Assignee: AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO - A.C.R.A.F. - S.P.A. ENUNCIABILE ANCHE A.C.R.A.F. S.P.A. , ACRAF S.P.A. , ANGELINI S.P.A. - WO2016/96686, 2016, A1 Location in patent: Page/Page column 111-112
  • 10
  • [ 1260639-98-2 ]
  • 6-bromo-N-(3-methoxy-4-piperidyl)pyridine-2-carboxamide hydrochloride [ No CAS ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1: triethylamine; 1-propanephosphonic acid cyclic anhydride / N,N-dimethyl-formamide / 1 h / 25 °C 2: hydrogenchloride / ethyl acetate / 1 h / 25 °C
Reference： [1]Current Patent Assignee: PMV PHARMACEUTICALS INC - WO2021/262596, 2021, A1
  • 11
  • [ 1260639-98-2 ]
  • 6-bromo-N-(3-methoxy-1-methyl-4-piperidyl)pyridine-2-carboxamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 3 steps 1: triethylamine; 1-propanephosphonic acid cyclic anhydride / N,N-dimethyl-formamide / 1 h / 25 °C 2: hydrogenchloride / ethyl acetate / 1 h / 25 °C 3: sodium tris(acetoxy)borohydride / dichloromethane; water monomer / 1 h / 25 °C
Reference： [1]Current Patent Assignee: PMV PHARMACEUTICALS INC - WO2021/262596, 2021, A1
  • 12
  • [ 21190-87-4 ]
  • [ 1260639-98-2 ]
  • tert-butyl 4-[(6-bromopyridine-2-carbonyl)amino]-3-methoxy-piperidine-1-carboxylate [ No CAS ]
YieldReaction ConditionsOperation in experiment
90.6% With 1-propanephosphonic acid cyclic anhydride; triethylamine In N,N-dimethyl-formamide at 25℃; for 1h; 16 To a solution of 6-bromopyridine-2-carboxylic acid (0.35 g, 1.73 mmol, 1 eq) in DMF (4 mL) was added TEA (876.6 mg, 8.66 mmol, 1.21 mL, 5 eq) and tert-butyl 4-amino-3-methoxy-piperidine-1-carboxylate (518.7 mg, 2.25 mmol, 1.3 eq). Then T3P (1.65 g, 2.6 mmol, 1.55 mL, 50% purity, 1.5 eq) was added to the reaction and the reaction was stirred at 25 °C for 1 h. TLC showed that the reaction was complete. The reaction mixture was diluted with H2O (50 mL). The mixture was extracted with EtOAc (2 x 50 mL), and the combined organic layers were washed with H2O (2 x 50 mL) and brine (2 x 50 mL), dried over anhydrous Na2SO4, filtered, and concentrated in vacuo to give a residue. The residue was purified by column chromatography (SiO2, PE:EtOAc =10:1 to 6:1) to afford the title compound tert-butyl 4-[(6-bromopyridine-2-carbonyl) amino]-3-methoxy-piperidine-1-carboxylate (0.65 g, 1.57 mmol, 90.6% yield) as a yellow oil.
90.6% With 1-propanephosphonic acid cyclic anhydride; triethylamine In N,N-dimethyl-formamide at 25℃; for 1h; 16 To a solution of 6-bromopyridine-2-carboxylic acid (0.35 g, 1.73 mmol, 1 eq) in DMF (4 mL) was added TEA (876.6 mg, 8.66 mmol, 1.21 mL, 5 eq) and tert-butyl 4-amino-3-methoxy-piperidine-1-carboxylate (518.7 mg, 2.25 mmol, 1.3 eq). Then T3P (1.65 g, 2.6 mmol, 1.55 mL, 50% purity, 1.5 eq) was added to the reaction and the reaction was stirred at 25 °C for 1 h. TLC showed that the reaction was complete. The reaction mixture was diluted with H2O (50 mL). The mixture was extracted with EtOAc (2 x 50 mL), and the combined organic layers were washed with H2O (2 x 50 mL) and brine (2 x 50 mL), dried over anhydrous Na2SO4, filtered, and concentrated in vacuo to give a residue. The residue was purified by column chromatography (SiO2, PE:EtOAc =10:1 to 6:1) to afford the title compound tert-butyl 4-[(6-bromopyridine-2-carbonyl) amino]-3-methoxy-piperidine-1-carboxylate (0.65 g, 1.57 mmol, 90.6% yield) as a yellow oil.
Reference： [1]Current Patent Assignee: PMV PHARMACEUTICALS INC - WO2021/262596, 2021, A1 Location in patent: Paragraph 0742
[2]Current Patent Assignee: PMV PHARMACEUTICALS INC - WO2021/262596, 2021, A1 Location in patent: Paragraph 0742

Tags: 1260639-98-2 synthesis path| 1260639-98-2 SDS| 1260639-98-2 COA| 1260639-98-2 purity| 1260639-98-2 application| 1260639-98-2 NMR| 1260639-98-2 COA| 1260639-98-2 structure

Related Products
Historical Records

Related Functional Groups of
[ 1260639-98-2 ]

Amines

Chemical Structure| 1171124-68-7

[ 1171124-68-7 ]

cis-tert-Butyl 4-amino-3-methoxypiperidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 1232059-97-0

[ 1232059-97-0 ]

trans-tert-Butyl 4-amino-3-methoxypiperidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 1363378-22-6

[ 1363378-22-6 ]

(3R,4S)-tert-Butyl 4-amino-3-methoxypiperidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 1171125-92-0

[ 1171125-92-0 ]

(3S,4R)-tert-Butyl 4-amino-3-methoxypiperidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 1419101-07-7

[ 1419101-07-7 ]

cis-1-Boc-4-methylamino-3-methoxypiperidine

Similarity: 0.98

Amides

Chemical Structure| 1171124-68-7

[ 1171124-68-7 ]

cis-tert-Butyl 4-amino-3-methoxypiperidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 1232059-97-0

[ 1232059-97-0 ]

trans-tert-Butyl 4-amino-3-methoxypiperidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 1363378-22-6

[ 1363378-22-6 ]

(3R,4S)-tert-Butyl 4-amino-3-methoxypiperidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 1171125-92-0

[ 1171125-92-0 ]

(3S,4R)-tert-Butyl 4-amino-3-methoxypiperidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 1419101-07-7

[ 1419101-07-7 ]

cis-1-Boc-4-methylamino-3-methoxypiperidine

Similarity: 0.98

Ethers

Chemical Structure| 1171124-68-7

[ 1171124-68-7 ]

cis-tert-Butyl 4-amino-3-methoxypiperidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 1232059-97-0

[ 1232059-97-0 ]

trans-tert-Butyl 4-amino-3-methoxypiperidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 1363378-22-6

[ 1363378-22-6 ]

(3R,4S)-tert-Butyl 4-amino-3-methoxypiperidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 1171125-92-0

[ 1171125-92-0 ]

(3S,4R)-tert-Butyl 4-amino-3-methoxypiperidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 1419101-07-7

[ 1419101-07-7 ]

cis-1-Boc-4-methylamino-3-methoxypiperidine

Similarity: 0.98

Related Parent Nucleus of
[ 1260639-98-2 ]

Piperidines

Chemical Structure| 1171124-68-7

[ 1171124-68-7 ]

cis-tert-Butyl 4-amino-3-methoxypiperidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 1232059-97-0

[ 1232059-97-0 ]

trans-tert-Butyl 4-amino-3-methoxypiperidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 1363378-22-6

[ 1363378-22-6 ]

(3R,4S)-tert-Butyl 4-amino-3-methoxypiperidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 1171125-92-0

[ 1171125-92-0 ]

(3S,4R)-tert-Butyl 4-amino-3-methoxypiperidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 1419101-07-7

[ 1419101-07-7 ]

cis-1-Boc-4-methylamino-3-methoxypiperidine

Similarity: 0.98